Get started
Kodiak Sciences IncKodiak Sciences IncKodiak Sciences Inc

Kodiak Sciences Inc

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

KOD chart


Full chart

KOD upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪455.20 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.65 USD
Net income (FY)
‪−260.49 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪48.64 M‬
Beta (1Y)
2.90

Employees


Employees (FY)
111
Change (1Y)
−1 −0.89%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−2.35 M‬ USD

About Kodiak Sciences Inc


Sector
Health Technology
Industry
Biotechnology
CEO
Victor Perlroth
Website
kodiak.com
Headquarters
Palo Alto
Founded
2009
FIGI
BBG00BVR0D02
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

KOD news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of KOD is 8.65 USD — it has decreased by −0.35% in the past 24 hours. Watch Kodiak Sciences Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Kodiak Sciences Inc stocks are traded under the ticker KOD.
KOD stock has risen by 2.61% compared to the previous week, the month change is a 53.10% rise, over the last year Kodiak Sciences Inc has showed a 195.22% increase.
We've gathered analysts' opinions on Kodiak Sciences Inc future price: according to them, KOD price has a max estimate of 20.00 USD and a min estimate of 2.00 USD. Watch KOD chart and read a more detailed Kodiak Sciences Inc stock forecast: see what analysts think of Kodiak Sciences Inc and suggest that you do with its stocks.
KOD reached its all-time high on Feb 10, 2021 with the price of 171.21 USD, and its all-time low was 1.37 USD and was reached on Oct 27, 2023. View more price dynamics on KOD chart.
See other stocks reaching their highest and lowest prices.
KOD stock is 7.44% volatile and has beta coefficient of 2.90. Track Kodiak Sciences Inc stock price on the chart and check out the list of the most volatile stocks — is Kodiak Sciences Inc there?
Today Kodiak Sciences Inc has the market capitalization of ‪455.20 M‬, it has decreased by −0.78% over the last week.
Yes, you can track Kodiak Sciences Inc financials in yearly and quarterly reports right on TradingView.
Kodiak Sciences Inc is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
KOD earnings for the last quarter are −0.84 USD per share, whereas the estimation was −0.90 USD resulting in a 7.14% surprise. The estimated earnings for the next quarter are −0.88 USD per share. See more details about Kodiak Sciences Inc earnings.
Kodiak Sciences Inc revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
KOD net income for the last quarter is ‪−43.95 M‬ USD, while the quarter before that showed ‪−45.12 M‬ USD of net income which accounts for 2.60% change. Track more Kodiak Sciences Inc financial stats to get the full picture.
No, KOD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 111.00 employees. See our rating of the largest employees — is Kodiak Sciences Inc on this list?
Like other stocks, KOD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kodiak Sciences Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kodiak Sciences Inc technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kodiak Sciences Inc stock shows the buy signal. See more of Kodiak Sciences Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.